Zimmer Biomet Holdings (ZBH) Total Current Liabilities (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted Total Current Liabilities of $3.0 billion for Q2 2026, up 5.21% on a QoQ basis from $2.9 billion in Q1 2026, and up 11.63% year-over-year from $2.7 billion in Q2 2025.
Analysis
Zimmer Biomet Holdings (ZBH) Total Current Liabilities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings has reported Total Current Liabilities for 18 years, with the latest figure at $3.0 billion in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 11.63% year-over-year to $3.0 billion in Q2 2026; TTM through Jun 2026 was $3.0 billion, a 11.63% increase from a year earlier, with the FY2025 full-year figure at $2.6 billion, up 5.42% from the prior year.
- Total Current Liabilities was $3.0 billion for Q2 2026 at Zimmer Biomet Holdings, up from $2.9 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $3.6 billion in Q2 2024, with the low at $2.1 billion in Q3 2023.
- Average Total Current Liabilities over 5 years is $2.6 billion, with a median of $2.5 billion recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities soared 72.4% in 2024, then plunged 32.72% in 2025.
- Over 5 years, Total Current Liabilities stood at $2.4 billion in 2022, then advanced by 21.17% to $2.9 billion in 2023, then slipped by 14.23% to $2.5 billion in 2024, then advanced by 5.42% to $2.6 billion in 2025, then advanced by 16.64% to $3.0 billion in 2026.
- The last three Total Current Liabilities figures came in at $3.0 billion (Q2 2026), $2.9 billion (Q1 2026), and $2.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 177.87 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.96 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 118.17 Bn | 109.35 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 106.33 Bn | 102.85 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 66.46 Bn | 65.93 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.59 Bn | 45.34 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 33.96 Bn | 32.51 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 31.98 Bn | 30.03 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Zimmer Biomet Holdings | 18.25 Bn | 17.84 Bn | 1.54 Bn | 3.01 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.01 Bn |
| Mar 31, 2026 | 2.86 Bn |
| Dec 31, 2025 | 2.58 Bn |
| Sep 30, 2025 | 2.40 Bn |
| Jun 30, 2025 | 2.70 Bn |
| Mar 31, 2025 | 2.29 Bn |
| Dec 31, 2024 | 2.45 Bn |
| Sep 30, 2024 | 3.57 Bn |
| Jun 30, 2024 | 3.61 Bn |
| Mar 31, 2024 | 2.80 Bn |
| Dec 31, 2023 | 2.86 Bn |
| Sep 30, 2023 | 2.07 Bn |
| Jun 30, 2023 | 2.23 Bn |
| Mar 31, 2023 | 2.34 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.30 Bn |
| Jun 30, 2022 | 2.46 Bn |
| Mar 31, 2022 | 2.67 Bn |
| Dec 31, 2021 | 3.47 Bn |
| Sep 30, 2021 | 2.94 Bn |